Since the restoration of diplomatic relations between the United States and Cuba, the US pharmaceutical industry has rushed to Cuba, hoping to establish cooperative relations with Cuba in drug research and development and manufacturing. Because the United States is well aware of Cuba's achievements in the pharmaceutical industry. As far back as the embargo era, the United States secretly used special "good drugs" developed by Cuba, such as the meningitis vaccine developed by Cuba and the vaccine that stimulates the immune system against lung cancer cells.
Cuba's strengths in pharmaceuticals are vaccines, generics and alternatives. This is because the collapse of the Soviet Union and the economic sanctions imposed by the United States have left Cuba in the embargo without foreign exchange to import drugs and must produce them itself, and it was in this context that generic and alternative drugs were forced out.
At first, it was a last resort, but thanks to the excellent knowledge of modern medicine, Cuban medical personnel have developed a series of new treatment and health care methods that combine tradition and modernity. For example, a substance is extracted from the venom of the blue scorpion unique to Cuba, which has a strong anti-cancer effect. It is still in the experimental stage, but many cancer patients have obtained good results after trial.
U.S. pharmaceutical companies generally do not pay attention to the development of vaccines, because the long-term profits of vaccines are very low, and when people use vaccines, they will not get sick and do not need to buy drugs. Cuba's pharmaceutical companies are not private enterprises that seek to maximize profits, but are part of the public ownership of the planned economy, and a major consideration in choosing to focus on the development of drugs is how to make people less sick and use less drugs in order to reduce long-term public medical expenditure. As a result, Cuba has developed a series of good drugs that Europe and the United States admire, such as the only drug in the world that can effectively fight diabetic foot ulcers, which can reduce the amputation rate caused by ulcers by 80%.
(1/text)